Biology subjects

Hoeksma, J.

Publications and source records attributed to Hoeksma, J..

6 recordsLinked to original sources

bioRxiv2024

Migration of Kupffers vesicle derived cells is essential for tail morphogenesis in zebrafish embryos

A phenotypic screen of fungal filtrates on developing zebrafish embryos identified metabolites from the fungus Ceratocystis populicola to induce ectopic tail formation, including a split notochord and a duplicated caudal fin. Chemical analyses led to the identification of monoterpene alcohols, in particular geraniol, as active compounds inducing ectopic tail formation during a specific 4 h time window during tail bud stage. Embryos from Tupfel long fin zebrafish (TL) were more susceptible to ectopic tail formation by geraniol than embryos from Wild Indian Karyotpe (WIK) zebrafish, indicating zebrafish strain specificity. RNA sequencing on tail buds of 15-somite stage embryos revealed downregulation of essential genes of the retinoic acid signaling pathway and differential expression of cyp26a1 and fgf8a and downstream hox-genes was validated. Time-lapse imaging revealed that Kupffers vesicle derived cells failed to migrate shorty after Kupffers vesicle collapse upon geraniol treatment and these cells failed to merge with progenitors from the tail bud. Instead, these cells contributed to an ectopic tail, expressing markers for presomitic mesoderm, somite and notochord tissue. Taken together, our data suggests that Kupffers vesicle cells harbor tail progenitor capacity, and proper migration of these cells is essential for normal tail morphogenesis. Summary StatementInhibition of Kupffers vesicle derived cell migration affected tail morphogenesis and resulted in ectopic tail formation in zebrafish embryos.

developmental biology↗

bioRxiv2022

Paecilomycone inhibits quorum sensing in Gram-negative bacteria

Pseudomonas aeruginosa is an opportunistic pathogen that causes major healthcare concerns due to its virulence and high intrinsic resistance to antimicrobial agents. Therefore, new treatments are highly needed. An interesting approach is to target quorum sensing (QS). QS regulates the production of a wide variety of virulence factors and biofilm formation in P. aeruginosa. This study describes the identification of paecilomycone as inhibitor of QS in both C. violaceum and P. aeruginosa. Paecilomycone strongly inhibited the production of virulence factors, including various phenazines, and biofilm formation. In search of the working mechanism, we found that paecilomycone inhibited the production of 4-hydroxy-2-heptylquinoline (HHQ) and 3,4- dihydroxy-2-heptylquinoline (PQS), but not 2-aminoacetophenone (2-AA). We suggest that paecilomycone affects QS in P. aeruginosa by targeting the PqsBC complex and alternative targets, or alters processes that influence the enzymatic activity of the PqsBC complex. The toxicity of paecilomycone towards eukaryotic cells and organisms was low, making it an interesting lead for further clinical research. ImportanceAntibiotics are becoming less effective against bacterial infections due to the evolution of resistance among bacteria. Pseudomonas aeruginosa is a Gram-negative pathogen that causes major healthcare concerns and is difficult to treat due to its high intrinsic resistance to antimicrobial agents. Therefore, new targets are needed and an interesting approach is to target quorum sensing (QS). QS is the communication system in bacteria that regulates multiple pathways including the production of virulence factors and biofilm formation, which leads to high toxicity in the host and low sensitivity to antibiotics, respectively. We found a compound, named paecilomycone, which inhibited biofilm formation and the production of various virulence factors in P. aeruginosa. The toxicity of paecilomycone towards eukaryotic cells and organisms was low, making it an interesting lead for further clinical research.

microbiology↗

bioRxiv2021

Harzianic Acid has multi-target antimicrobial activity against Gram-Positive Bacteria

The thermophilic fungus Oidiodendron flavum is a saprobe that is commonly isolated from soil. Here, we identified a Gram-positive bacteria-selective antimicrobial secondary metabolite from this fungal species, harzianic acid (HA). Using Bacillus subtilis strain 168 combined with several assays, we found that HA targeted the cell membrane, though only at high concentrations. To further study the antimicrobial activity of HA, we isolated an HA-resistant strain, Bacillus subtilis strain M9015, and discovered that the mutant has more translucent colonies, has cross resistance to rifampin, and harbors five mutations in the coding region of four distinct genes. Further analysis of these genes indicated that the mutation in atpE might be responsible for the translucency of the colony, and mutation in yusO for resistance to both HA and rifampin. We conclude that HA is a multi-target antimicrobial agent against Gram-positive bacteria.

microbiology↗

bioRxiv2021

Classification of antimicrobial mechanism of action using bacterial time-lapse imaging

Antimicrobial resistance is a major threat to human health. Basic knowledge of antimicrobial mechanism of action (MoA) is imperative for patient care and for identification of novel antimicrobials. However, the process of antimicrobial MoA identification is relatively laborious. Here, we developed a simple, quantitative time-lapse fluorescence imaging method, Dynamic Bacterial Morphology Imaging (DBMI), to facilitate this process. It uses a membrane dye and a nucleoid dye to track the morphological changes of single Bacillus subtilis cells in response to antimicrobials for up to 60 min. DBMI of bacterial cells facilitated assignment of the MoAs of 14 distinct, known antimicrobial compounds to the five main classes. Using this method, we found that the poorly studied antimicrobial, harzianic acid, a secondary metabolite that we purified from the fungal culture of Oidiodendron flavum, targets the cell envelope. We conclude that DBMI is a simple method, which facilitates rapid classification of the MoA of antimicrobials in functionally distinct classes.

microbiology↗

bioRxiv2020

Peptide-based Inhibitors of Protein-Protein Interactions of Src Homology 2 Domain-Containing Phosphatase 2

We developed a new class of inhibitors of protein-protein interactions of the SHP2 phosphatase, which is pivotal in multiple signaling pathways and a central target in the therapy of cancer and rare diseases. Currently available SHP2 inhibitors target the catalytic site or an allosteric pocket but lack specificity or are ineffective on disease-associated SHP2 mutants. Based on the consideration that pathogenic lesions cause signaling hyperactivation due to increased SHP2 association with cognate proteins, we developed peptide-based molecules with low nM affinity for the N-terminal Src homology domain of SHP2, good selectivity, stability to degradation and an affinity for pathogenic variants of SHP2 up to 20 times higher than for the wild-type protein. The best peptide reverted the effects of a pathogenic variant (D61G) in zebrafish embryos. Our results provide a novel route for SHP2-targeted therapies and a tool to investigate the role of protein-protein interactions in the function of SHP2.

biophysics↗

bioRxiv2020

Cercosporamide inhibits bone morphogenetic protein receptor type I kinase activity in zebrafish

Zebrafish models are well established tools for investigating underlying mechanisms of diseases. Here, we identified cercosporamide, a metabolite from the fungus Ascochyta aquiliqiae, as a potent bone morphogenetic protein (BMP) type I receptor kinase inhibitor through a zebrafish embryo phenotypic screen. The developmental defects in zebrafish, including lack of the ventral fin induced by cercosporamide was strikingly similar as the phenotypes caused by renowned small molecule BMP type I receptor kinase inhibitors and inactivating mutations in zebrafish BMP receptors. In mammalian cell-based assays, cercosporamide blocked BMP/SMAD-dependent transcriptional reporter activity and BMP-induced SMAD1/5-phosphorylation. Biochemical assays with a panel of purified recombinant kinases demonstrated that cercosporamide directly inhibited kinase activity of BMP type I receptors (also called activin receptor-like kinases (ALKs)). In mammalian cells, cercosporamide selectively inhibited constitutively active BMP type I receptor-induced SMAD1/5 phosphorylation. Importantly, cercosporamide rescued the developmental defects caused by constitutively active Alk2 in zebrafish embryos. Taken together, we believe cercosporamide may be the first of a new class of molecules with potential to be developed further for clinical use against diseases that are causally linked to overactivation of BMP receptor signaling, including Fibrodysplasia ossificans progressiva and diffuse intrinsic pontine glioma.View Full Text

pharmacology and toxicology↗